Individual holder
NCARDIA B V
NL·6 granted patents·4 pending applications·1 citations·filing 2014–2024
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
10 records- 0176US2025066734A1Culture medium composition for maturating cardiomyocytes derived from pluripotent mammalian stem cellsNCARDIA B V·Filed 2024·Application pending·0 cites
- 0271US10696947B2Culture medium composition for maturating cardiomyocytes derived from pluripotent mammalian stem cellsNCARDIA B V·Filed 2014·Granted Jun 30, 2020·1 cites·25 claims
- 0364US12043846B2Cardiomyocytes derived from pluripotent mammalian stem cellsNCARDIA B V·Filed 2020·Granted Jul 23, 2024·0 cites·43 claims
- 0453US2023295570A1Closed manufacturing processes for large scale manufacturing of pluripotent stem cell derived cellsNCARDIA B V·Filed 2021·Application pending·0 cites
- 0553US2022025333A1In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell populationNCARDIA B V·Filed 2021·Application pending·0 cites
- 0651US11136551B2In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell populationNCARDIA B V·Filed 2016·Granted Oct 5, 2021·0 cites·28 claims
- 0739US2021147805A1In vitro method for providing stem cell derived cardiomyocytesNCARDIA B V·Filed 2018·Application pending·0 cites
- 0832US10844354B2Cardiomyocyte maturationNCARDIA B V·Filed 2015·Granted Nov 24, 2020·0 cites·14 claims
- 0931US10613078B2Assays for measuring cardiotoxicityNCARDIA B V·Filed 2016·Granted Apr 7, 2020·0 cites·16 claims
- 1030US11773375B2In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytesNCARDIA B V·Filed 2017·Granted Oct 3, 2023·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when NCARDIA B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →